The Clinical Relevance of IL-17-Producing CD4+CD161+ Cell and Its Subpopulations in Primary Sjögren’s Syndrome

Figure 5

Percentages of CD4+CD161+ T (a to e) and CD4+CD25−CD161+ T (f to i) cells according to the disease features. ANA: antinuclear antibody; ESR: erythrocyte sedimentation rate; ESSDAI: the EULAR-SS Disease Activity Index. .

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)